Achievement of response over time with fremanezumab in the treatment of chronic and episodic migraine (vol 19, pg P11, 2018)

被引：0
|
作者：
Silberstein, Stephen D. [1 ]
Lipton, Richard B. [2 ]
Diamond, Merle L. [3 ]
Cohen, Joshua M. [4 ]
Yang, Ronghua [4 ]
Jiang, Bo [4 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Diamond Headache Clin Ltd, Chicago, IL USA
[4] Teva Pharmaceut, Frazer, PA USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 39 条
  • [1] Achievement of Response over Time with Fremanezumab in the Treatment of Chronic and Episodic Migraine
    Silberstein, S. D.
    Lipton, R. B.
    Diamond, M. L.
    Cohen, J. M.
    Yang, R.
    Jiang, B.
    HEADACHE, 2018, 58 (08): : 1300 - 1301
  • [2] Achievement of response over time with fremanezumab in the treatment of chronic and episodic migraine
    Silberstein, Stephen D.
    Lipton, Richard B.
    Diamond, Merle L.
    Cohen, Joshua M.
    Yang, Ronghua
    Jiang, Bo
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [3] Reversion of patients with chronic migraine to an episodic migraine classification with fremanezumab treatment (vol 19, P7, 2018)
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [4] The impact of fremanezumab on symptoms associated with migraine in patients with episodic migraine (vol 19, pg P3, 2018)
    Brandes, Jan L.
    Yeung, Paul P.
    Aycardi, Ernesto
    Yang, Ronghua
    Ma, Yuju
    Cohen, Joshua M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [5] Achievement of Response with Fremanezumab in the Treatment of Chronic Migraine
    Winner, Paul K.
    Bigal, Marcelo E.
    Aycardi, Ernesto
    Yeung, Paul P.
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    NEUROLOGY, 2018, 90
  • [6] Achievement of Response with Fremanezumab in the Treatment of Chronic Migraine
    Winner, P. K.
    Bigal, M.
    Aycardi, E.
    Yeung, P. P.
    Blankenbiller, T.
    Grozinski-Wolff, M.
    Yang, R.
    Ma, Y.
    HEADACHE, 2018, 58 : 78 - 79
  • [7] Epidemiology of chronic and episodic migraine in Europe (vol 19, pg P136, 2018)
    Benhaddi, Hicham
    Fitzgerald, Timothy
    McCabe, Sophie
    Zeidman, Ruth
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [8] The impact of fremanezumab on medication overuse in patients with chronic migraine (vol 19, pg P12, 2018)
    Silberstein, Stephen D.
    Ashina, Sait
    Katsarava, Zaza
    Bibeau, Kristen
    Seminerio, Michael J.
    Harlow, Danielle E.
    Cohen, Joshua M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [9] The impact of fremanezumab on symptoms associated with migraine in patients with chronic migraine (vol 19, P4, 2018)
    McAllister, Peter
    Yeung, Paul P.
    Aycardi, Ernesto
    Yang, Ronghua
    Ma, Yuju
    Cohen, Joshua M.
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [10] Improvement in Response over Time with Fremanezumab in Patients Who Reverted from a Chronic to an Episodic Migraine Classification
    Singh, R. B. Halker
    Marmura, M. J.
    Cohen, J. M.
    Yang, R.
    HEADACHE, 2019, 59 : 108 - 108
1234